Take Action
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Backgrounder
Biosimilars Bulletin
Blog
Council Resource
Event
Handbook
Infographic
Issue Brief
Media
Member Spotlight
Partner Resource
Policy Recommendation
Press Release
Report
Statement
Video
Whitepapers

In the News

Senate passes inflation reduction act
AAM Statement on Senate Passage of Inflation Reduction Act
August 7, 2022
Inflation reduction act, biosimilars
Inflation Reduction Act Would Stifle Biosimilar Competition and Savings
August 3, 2022
US Capitol, Build Back Better bill, BBB
AAM Statement on BBB 2.0
July 7, 2022
Federal Trade Commission must investigate PBMs
AAM Statement in Response to Federal Trade Commission Request for Information on PBM Business Practices
May 23, 2022
Biosimilars Policy
Association for Accessible Medicines Names Craig Burton as Senior Vice President, Policy & Strategic Alliances, and Executive Director of the Biosimilars Council
May 16, 2022
HHS Finds Biosimilars Use Results in “Significant Spending Reduction” For Medicare and Its Beneficiaries
April 1, 2022

Filter by Keyword

Filter by Audience

Filter by Category

Filter by Keyword

Filter by Issue

Filter by Category

Recent Tweets

Biosimilars CouncilFollow2,54910,203

Biosimilars Council advocates for policies that support patient access to biosimilar medicines. Division of @AccessibleMeds | https://t.co/73dlNwCdqQ…

Biosimilars Council
BiosimsCouncil avatarBiosimilars Council@BiosimsCouncil·
19h 1558153548000641029

The #GRxBiosims 2022 conference takes place in North Bethesda, Maryland November 7-9!

Join us to learn invaluable information & insights on generics and #biosimilars from industry experts.

Register today ➡️ https://www.grxbiosims.org/

Twitter feed video.
Image for the Tweet beginning: The #GRxBiosims 2022 conference takes
Reply on Twitter 1558153548000641029Retweet on Twitter 1558153548000641029Like on Twitter 1558153548000641029Twitter 1558153548000641029
Load More...